Systemic siRNA Nanoparticle-Based Drugs Combined with Radiofrequency Ablation for Cancer TherapyMuneeb Ahmed(Beth Israel Deaconess Medical Center), S. Nahum Goldberg(Beth Israel Deaconess Medical Center)PLoS ONEJuly 8, 201510.1371/journal.pone.0128910Cited by 43SaveCiteExport RISWatch citationsRelated PapersConsensus Guidelines for the Definition of Time-to-Event End Points in Image-guided Tumor Ablation: Results of the SIO and DATECAN Initiative|Radiology|2021|168